Emtriva
- Product NDC
- 70518-1847
- 11-digit product format
- 705181847
- Labeler code
- 70518
- Product ID
- 70518-1847_da41ab3c-c728-d7ae-e053-2995a90aac7c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- EMTRICITABINE
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- NDA021500
- Marketing category
- NDA
- Marketing start
- 2019-02-04
- Marketing end
- 0000-00-00
- Substance
- EMTRICITABINE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-1847-0 | 70518184700 | 4 CAPSULE in 1 BLISTER PACK (70518-1847-0) | 4 capsule | 2019-02-04 | 0000-00-00 | No | No | Current |